Detection and quantification of rituximab in the human urine
Author:
Publisher
Elsevier BV
Subject
Immunology,Immunology and Allergy
Reference8 articles.
1. Efficacy and safety of subcutaneous rituximab versus intravenous rituximab for first-line treatment of follicular lymphoma (SABRINA): a randomised, open-label, phase 3 trial;Davies;Lancet Haematol.,2017
2. Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis;Fornoni;Sci. Transl. Med.,2011
3. A review of the current use of rituximab in autoimmune diseases;Gürcan;Int. Immunopharmacol.,2009
4. Rituximab;Keating;Drugs,2010
5. Surface IgM-kappa specificity on a Burkitt lymphoma cell in vivo and in derived culture lines;Klein;Cancer Res.,1968
Cited by 34 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Novel approaches to primary membranous nephropathy: Beyond the KDIGO guidelines;European Journal of Pharmacology;2024-11
2. A novel dosing approach for rituximab in glomerular diseases based on a population pharmacokinetic analysis;Biomedicine & Pharmacotherapy;2024-06
3. Low Dose Rituximab and Calcineurin Inhibitor Combination as an Effective Treatment Strategy in Relapsed Primary Membranous Nephropathy;2024-05-30
4. Early Rituximab as an Add-On Therapy in Children With the Initial Episode of Nephrotic Syndrome;Kidney International Reports;2024-05
5. Predictors and prognostic factors influencing outcomes of anti-CD20 monoclonal antibodies in systemic lupus erythematosus: A systematic review update;Seminars in Arthritis and Rheumatism;2024-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3